Phillips-Medisize, a Molex company, has appointed Michael Ratigan to Vice President of Global Sales. The company is growing in the biopharma drug delivery devices, consumable diagnostics and medical devices markets.
“Throughout Mike's career he has demonstrated strong commercial leadership skills in three mature publicly traded companies,” remarked Matt Jennings, Chair and CEO of Phillips-Medisize.
“He is a seasoned executive with a proven track record in business-to-business models serving the life science markets of medical devices, biopharmaceuticals and pharmaceuticals.”
Ratigan comes to Phillips-Medisize with more than 25 years of experience in the healthcare and life sciences space. He has spent the past six years at Unilife Corporation as Senior VP and Chief Commercial Officer.
Ratigan began his career at Merck, with successful assignments at Stryker Orthopedics and Becton Dickinson medical pharmaceutical systems business.
He lived in Germany for seven years, where he was a founding member of two biotechnology drug discovery companies. Ratigan has experience across a number of leadership roles including sales, marketing, business development, strategy and general management.
